Twenty-Year Follow-Up of a Controlled Trial Comparing a Combination of Methotrexate Plus Cyclosporine with Cyclosporine Alone for Prophylaxis of Graft-versus-Host Disease in Patients Administered HLA-Identical Marrow Grafts for Leukemia
Authors:
Open Access
- 1 October 2005
- journal article
- other
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 11 (10) , 814-815
Abstract
No abstract availableThis publication has 2 references indexed in Scilit:
- Summarizing data on survival, relapse, and chronic graft‐versus‐host disease after bone marrow transplantation: motivation for and description of new methodsBritish Journal of Haematology, 1993
- Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for LeukemiaNew England Journal of Medicine, 1986